Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
Hocqueloux
L
L
Department of Infectious Disease, Saint-Louis Hospital, Paris, France.
Agbalika
F
F
Oksenhendler
E
E
Molina
J M
JM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D020276:HIV Long-Term Survivors; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000503:physiopathology / Q000821:virology; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010996:Pleural Effusion; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology; D013997:Time Factors
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D016898:Interferon-alpha; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir